| Drug Name | Forteo (Teriparatide) |
|---|---|
| Drug Class |
Anti-osteoporotic
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Orthopedic
|
| Risk |
Potential risk of osteosarcoma with the use of FORTEO (teriparatide) [rDNA origin] |
| Dear Healthcare provider letter DHPC |
|